MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/115/0.1/20.12.24 Stock

Warrant

DE000MG4D2Z2

Real-time Bid/Ask 04:04:22 2024-07-03 EDT
0.092 EUR / 0.171 EUR +21.10% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/115/0.1/20.12.24
Current month-0.91%
1 month-77.29%
Date Price Change
24-07-02 0.109 -12.10%
24-07-01 0.124 +12.73%
24-06-28 0.11 -7.56%
24-06-27 0.119 +6.25%
24-06-26 0.112 -5.08%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:52 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2Z
ISINDE000MG4D2Z2
Date issued 2024-05-16
Strike 115 $
Maturity 2024-12-20 (171 Days)
Parity 10 : 1
Emission price 1.08
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.1
Lowest since issue 0.106
Spread 0.022
Spread %16.54%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus